These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35025619)

  • 1. Mutant
    Singh A; Mencia-Trinchant N; Griffiths EA; Altahan A; Swaminathan M; Gupta M; Gravina M; Tajammal R; Faber MG; Yan L; Sinha E; Hassane DC; Hayes DN; Guzman ML; Iyer R; Wang ES; Thota S
    JCO Precis Oncol; 2022 Jan; 6():e2100309. PubMed ID: 35025619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study.
    Kusne Y; Lasho T; Finke C; Elsabbagh Z; McCue S; Hobday T; Starr J; Bekaii-Saab T; Halfdanarson TR; Patnaik MM; Ou FS; Sonbol MB
    JCO Precis Oncol; 2024 Jun; 8():e2400143. PubMed ID: 38976813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis and Therapy-Related Myeloid Neoplasms After Autologous Transplant for Hodgkin Lymphoma.
    Yan C; Richard MA; Gibson CJ; He J; Bosworth A; Crossman DK; Singh P; Hageman L; Kalra R; Armenian SH; Vose J; Weisdorf DJ; Ebert BL; Yasui Y; Forman SJ; Bhatia R; Bhatia S
    J Clin Oncol; 2024 Jul; 42(20):2415-2424. PubMed ID: 38635938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.
    Takahashi K; Nakada D; Goodell M
    J Clin Invest; 2024 Oct; 134(19):. PubMed ID: 39352380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis-derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders.
    Awada H; Gurnari C; Visconte V; Durmaz A; Kuzmanovic T; Awada H; Tu ZJ; Cook JR; Bolwell BJ; Sobecks R; Kalaycio M; Bosler D; Maciejewski JP
    Leukemia; 2024 Jun; 38(6):1266-1274. PubMed ID: 38684821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy.
    Hsu JI; Dayaram T; Tovy A; De Braekeleer E; Jeong M; Wang F; Zhang J; Heffernan TP; Gera S; Kovacs JJ; Marszalek JR; Bristow C; Yan Y; Garcia-Manero G; Kantarjian H; Vassiliou G; Futreal PA; Donehower LA; Takahashi K; Goodell MA
    Cell Stem Cell; 2018 Nov; 23(5):700-713.e6. PubMed ID: 30388424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer.
    Arends CM; Kopp K; Hablesreiter R; Estrada N; Christen F; Moll UM; Zeillinger R; Schmitt WD; Sehouli J; Kulbe H; Fleischmann M; Ray-Coquard I; Zeimet A; Raspagliesi F; Zamagni C; Vergote I; Lorusso D; Concin N; Bullinger L; Braicu EI; Damm F
    Leukemia; 2024 Jun; 38(6):1378-1389. PubMed ID: 38637689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis with
    Stelmach P; Richter S; Sauer S; Fabre MA; Gu M; Rohde C; Janssen M; Liebers N; Proynova R; Weinhold N; Raab MS; Goldschmidt H; Besenbeck B; Pavel P; Laier S; Trumpp A; Dietrich S; Vassiliou GS; Müller-Tidow C
    Haematologica; 2023 Dec; 108(12):3308-3320. PubMed ID: 37381752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPM1D in Solid and Hematologic Malignancies: Friend and Foe?
    Zhang L; Hsu JI; Goodell MA
    Mol Cancer Res; 2022 Sep; 20(9):1365-1378. PubMed ID: 35657598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal Hematopoiesis is Associated With Severe Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T-Cell (CART) Therapy.
    Goldsmith SR; Shouse G; Wong FL; Bosworth A; Iukuridze A; Chen S; Rhee JW; Mei M; Htut M; Janakiram M; Forman SJ; Pillai R; Budde LE; Armenian SH
    Transplant Cell Ther; 2024 Sep; 30(9):927.e1-927.e9. PubMed ID: 38871057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatase, Mg
    Husby S; Hjermind Justesen E; Grønbæk K
    Br J Haematol; 2021 Feb; 192(4):697-705. PubMed ID: 33616916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent Hematologic Dysfunction after Peptide Receptor Radionuclide Therapy with
    Bergsma H; van Lom K; Raaijmakers MHGP; Konijnenberg M; Kam BLBLR; Teunissen JJM; de Herder WW; Krenning EP; Kwekkeboom DJ
    J Nucl Med; 2018 Mar; 59(3):452-458. PubMed ID: 28775205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations.
    Mangaonkar AA; Patnaik MM
    Am J Hematol; 2023 Jun; 98(6):951-964. PubMed ID: 36938794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis and inflammation in the vasculature: CHIVE, a prospective, longitudinal clonal hematopoiesis cohort and biorepository.
    Shannon ML; Heimlich JB; Olson S; Debevec A; Copeland Z; Kishtagari A; Vlasschaert C; Snider C; Silver AJ; Brown D; Spaulding T; Bhatta M; Pugh K; Stockton SS; Ulloa J; Xu Y; Baljevic M; Moslehi J; Jahangir E; Ferrell PB; Slosky D; Bick AG; Savona MR
    Blood Adv; 2024 Jul; 8(13):3453-3463. PubMed ID: 38608257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study.
    Carlsen EA; Fazio N; Granberg D; Grozinsky-Glasberg S; Ahmadzadehfar H; Grana CM; Zandee WT; Cwikla J; Walter MA; Oturai PS; Rinke A; Weaver A; Frilling A; Gritti S; Arveschoug AK; Meirovitz A; Knigge U; Sorbye H
    Endocr Relat Cancer; 2019 Feb; 26(2):227-239. PubMed ID: 30540557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelotoxicity of Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Decade of Experience.
    Kesavan M; Turner JH
    Cancer Biother Radiopharm; 2016 Aug; 31(6):189-98. PubMed ID: 27419665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
    Franch-Expósito S; Mehine M; Ptashkin RN; Bolton KL; Bandlamudi C; Srinivasan P; Zhang L; Goodell MA; Gedvilaite E; Menghrajani K; Sánchez-Vela P; Mandelker D; Comen E; Norton L; Benayed R; Gao T; Papaemmanuil E; Taylor B; Levine R; Offit K; Stadler Z; Berger MF; Zehir A
    JCO Precis Oncol; 2023 Aug; 7():e2300070. PubMed ID: 37561983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.
    Mayerhofer C; Sedrak MS; Hopkins JO; Li T; Tayob N; Faggen MG; Sinclair NF; Chen WY; Parsons HA; Mayer EL; Lange PB; Basta AS; Perilla-Glen A; Lederman RI; Wong AR; Tiwari A; McAllister SS; Mittendorf EA; Gibson CJ; Burstein HJ; Kim AS; Freedman RA; Miller PG
    J Natl Cancer Inst; 2023 Aug; 115(8):981-988. PubMed ID: 37042724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation.
    Gramegna D; Bertoli D; Cattaneo C; Almici C; Re A; Belotti A; Borlenghi E; Lanzi G; Archetti S; Verardi R; Brugnoni D; Sciumè M; Daffini R; Roccaro AM; Tucci A; Rossi G
    Ann Hematol; 2022 Jun; 101(6):1227-1237. PubMed ID: 35380239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene
    Yura Y; Miura-Yura E; Katanasaka Y; Min KD; Chavkin N; Polizio AH; Ogawa H; Horitani K; Doviak H; Evans MA; Sano M; Wang Y; Boroviak K; Philippos G; Domingues AF; Vassiliou G; Sano S; Walsh K
    Circ Res; 2021 Sep; 129(6):684-698. PubMed ID: 34315245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.